Key Takeaway
Pranayama demonstrates significant benefits for respiratory conditions (asthma, COPD), cardiovascular health, and cancer-related symptoms across 18 controlled clinical trials, with strongest evidence in bronchial asthma.
Summary
This systematic review is the first to evaluate the therapeutic health effects of pranayama practiced alone (not combined with other yoga components) across controlled human trials. Searching PubMed, Web of Science, and Scopus through June 2017, the authors screened 669 articles and included 18 controlled clinical trials (13 randomized, 1 crossover) with sample sizes ranging from 16 to 160 participants and intervention durations from 4 days to 6 months.
The strongest evidence emerged for respiratory conditions: multiple trials in bronchial asthma patients showed significant improvements in pulse rate, systolic blood pressure, FVC, PEFR, and FEV1, along with reduced attack frequency, lower medication requirements, and improved quality of life. COPD patients showed improvements in symptom, activity, and impact scores. Cardiovascular benefits included significant reductions in systolic and diastolic blood pressure in hypertensive patients and anxiety reduction in cardiac patients.
In cancer patients, particularly breast cancer, pranayama significantly reduced cancer-related fatigue and improved emotional responses, sleep quality, and anxiety during chemotherapy. However, the overall quality of included studies was mixed: only 5 of 18 studies were rated good quality on the PEDro scale, while 6 were rated poor. The high heterogeneity across pranayama techniques, outcome measures, and populations prevented quantitative meta-analysis. Most studies (14 of 18) were conducted in India.
Methods
- Searched PubMed, Web of Science, and SciVerse Scopus for controlled clinical trials
- Keywords included "Pranayama," "Pranayam," and "Yogic Breathing Exercise"
- Included controlled human trials using pranayama as intervention with non-yoga control groups
- 669 initial articles; 405 after deduplication; 106 full-text reviewed; 18 included
- Pranayama types: Bhastrika, Kapalbhati, Nadi shodana, alternate nostril breathing
- Study quality assessed using PEDro scale (physiotherapy evidence database)
- Intervention durations ranged from 4 days to 6 months
- Narrative synthesis due to high heterogeneity preventing meta-analysis
Key Results
- Respiratory (8 studies): significant improvements in FVC, PEFR, FEV1, pulse rate, and systolic BP in asthma patients; reduced attack frequency and medication use
- COPD: improved symptom, activity, and impact scores
- Cardiovascular (4 studies): significant reductions in systolic and diastolic blood pressure in hypertension; anxiety reduction in MI and angiography patients
- Cancer (5 studies): significant reduction in cancer-related fatigue in breast cancer; improved emotional responses, sleep, and anxiety during chemotherapy
- Depression: significant reduction in depression scores in abused women
- Study quality: 5 good (PEDro 6-10), 7 fair (PEDro 4-5), 6 poor (PEDro <4)
- 14 of 18 studies conducted in India
Limitations
- High heterogeneity across pranayama techniques, outcomes, and populations prevented meta-analysis
- Only 5 of 18 studies rated good quality on PEDro scale
- Single-blinding inherent to behavioral interventions lowered quality scores
- Small sample sizes (16-160 participants per study)
- Geographic concentration in India limits generalizability
- Variable intervention durations (4 days to 6 months) make comparisons difficult
- Some studies lacked adequate control group descriptions